UK markets open in 4 hours 24 minutes

Pulmonx Corporation (LUNG)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
5.82-0.07 (-1.27%)
At close: 04:00PM EDT
5.82 0.00 (0.00%)
After hours: 04:02PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close5.89
Open5.97
Bid5.79 x 400
Ask5.85 x 200
Day's range5.71 - 5.98
52-week range5.67 - 14.84
Volume359,940
Avg. volume497,903
Market cap228.819M
Beta (5Y monthly)0.65
PE ratio (TTM)N/A
EPS (TTM)-1.54
Earnings date31 Jul 2024 - 05 Aug 2024
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target est14.83
  • Zacks

    How Much Upside is Left in Pulmonx (LUNG)? Wall Street Analysts Think 80.3%

    The consensus price target hints at an 80.3% upside potential for Pulmonx (LUNG). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.

  • GlobeNewswire

    Pulmonx Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

    REDWOOD CITY, Calif., May 06, 2024 (GLOBE NEWSWIRE) -- Pulmonx Corporation (Nasdaq: LUNG) (“Pulmonx” or the "Company"), a global leader in minimally invasive treatments for lung disease, today announced that the Compensation Committee of the Board of Directors of Pulmonx (the “Compensation Committee”) granted inducement awards consisting of a non-statutory stock option to purchase 241,409 shares of common stock and a time-based restricted stock unit award for 125,870 shares of common stock on Ma

  • Zacks

    Wall Street Analysts See a 56.11% Upside in Pulmonx (LUNG): Can the Stock Really Move This High?

    The consensus price target hints at a 56.1% upside potential for Pulmonx (LUNG). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.